Molecular Partners AG -ADRMOLN
13F holders, Q3 2024 (September 30)5holders −3
0new positions
3sold out
$4.95avg. 13F price*
At the end of Q3 2024, 5 institutions reported holding Molecular Partners AG -ADR (MOLN) in their 13F filings, down 3 from Q2 2024. 0 opened new positions and 3 sold out. The largest holders were BVF Inc. ($2.1M), Montanova Capital, LLC ($2.0M) and UBS Group AG ($27K).
- Company
- Molecular Partners AG -ADR
- CUSIP
- 60853G106
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 3 | $93K |
All 13F filers, Q2 2024 → Q3 2024: 1,918 shares bought and 12,881 shares sold, net −10,963 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 5 holders
| BVF Inc. | 0.06% | No change | 443,221 | $2.1M |
| Montanova Capital, LLC | 0.07% | No change | 400,000 | $2.0M |
| UBS Group AG | 0.00% | Add +51.6% | 5,246 | $27K |
| Morgan Stanley | 0.00% | Add +36.2% | 500 | $3K |
| Rhumbline Advisers | 0.00% | No change | 269 | $1K |
"% of holder's portfolio" is MOLN's weight in each manager's 13F, not the share of Molecular Partners AG -ADR the manager owns.